Radical prostatectomy (RRP) and brachytherapy have substantial effects on general and disease-speci®c health related quality of life (HRQOL) . These data represent the early results of a prospective, longitudinal study to determine the effects of brachytherapy and RRP on HRQOL.
Method
We used the RAND SF-36, the UCLA Prostate Cancer Index, the AUA Symptom Index (AUASI), and 2 validated scales measuring cancer interference with life and family to determine patients' HRQOL at baseline and at 1, 2, 4 and 8 months after treatment. Our study included 44 patients undergoing brachytherapy and 152 patients undergoing RRP.
Results
Mean age was 68 y in the brachytherapy patients and 60 y in the RRP patients (P 0.01). The two groups did not differ signi®cantly with respect to other sociodemographic or tumour characteristics.
Conclusion
At baseline, brachytherapy patients had slightly lower scores than RRP patients for the majority of the domains. However, 1 month after treatment brachytherapy patients had higher HRQOL scores than RRP patients. RRP patients had a dramatic increase between 1 and 2 months following treatment. For both groups, HRQOL at 2 months was similar to that at 4 months. At 8 months, signi®cant differences persisted. 
